Author:
Takenaka Takeaki,Itoh Kuniaki,Suzuki Takayo,Utsunomiya Atae,Matsuda Shin,Chou Takaaki,Sai Toshiaki,Sano Masayuki,Konda Susumu,Ohno Tatsuji,Mikuni Chikara,Deura Kijoh,Yamada Takashi,Mizorogi Fumi,Nagoshi Haruhisa,Tomonaga Masao,Hotta Tomomitsu,Kawano Kohichi,Tsushita Keitaro,Hirano Masami,Shimoyama Masanori,Group Lymphoma Study
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Myeloma Trialists' Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832-3842.
2. Takenaka T, Shirakawa S, Mikuni C, et al. Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisolone) and MP (melphalan, prednisolone) in multiple myeloma: a multi-center phase II study (JCOG8906). Jpn J Clin Oncol. 1999;29: 485-489.
3. Tanaka I, Kobayashi T, Shirakawa S, et al. Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureoid]-6-deoxy-3-D-glucopyranoside (MCNU) [in Japanese with English summary]. Jpn J Cancer Chemother. 1985;12:493-498.
4. Imamura Y, Takagi T, Yawata Y, et al. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Int J Hematol. 1994;59:113-123.
5. Wada M, Mizoguchi H, Kuriya S, et al. Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon 3 (ROAD-IN) and a randomized comparison of interferon 3 maintenance in multiple myeloma: a co-operative study in Japan. Br J Haematol. 2000;109:805-814.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献